Locations
Company type
Result types
Industries
Employees
Founding year
The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
SunRock Biopharma S.L
Santiago de Compostela, Spain
A
1-10 Employees
2014
Key takeaway
SunRock is focused on developing innovative therapeutic antibodies for cancer, specifically highlighting its work on novel HER3 bispecific antibody drug conjugates aimed at treating aggressive tumors. This approach addresses the urgent clinical need for more effective treatments in oncology.
Reference
Product
TRADBI | SunRock Biopharma
TRADBI - Novel HER3 Bispecific Antibody Drug Conjugates for the Treatment of Agressive Tumours.
Leadartis
Tres Cantos, Spain
A
1-10 Employees
-
Key takeaway
LeadArtis is a biopharmaceutical company focused on developing proprietary therapeutic antibodies, specifically a novel class called Trimerbodies, which exhibit higher multivalence and multispecificity than conventional immunoglobulins.
Reference
Core business
Our company - Leadartis
LeadArtis is a biopharmaceutical company engaged in the development of proprietary therapeutic antibodies We named these therapeutic antibodies Trimerbodies, with higher multivalence and multispecificity than the immunoglobulins, which are currently most prevalent on the market. Our drug candidates are derived from in-house R&D and our collaborations with reference research centers and other companies. We have several
ISOMAB CONSULTORES SL
Pozuelo de Alarcón, Spain
A
11-50 Employees
-
Key takeaway
IsomAb is focused on developing isoform specific antibodies, such as ISM-001, which targets the VEGF-A165b isoform of Vascular Endothelial Growth Factor-A (VEGF-A). This innovative approach aims to address treatment gaps for patients with conditions like ischemic disease, potentially offering new therapeutic options.
Reference
Core business
Home | IsomAb
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
RemAb Therapeutics
Barcelona, Spain
A
1-10 Employees
2018
Key takeaway
RemAb Therapeutics focuses on developing polymeric conjugates that target and bind to specific adverse antibodies, which can be relevant in the context of bispecific antibodies by addressing immune responses. Their platform is designed for the selective removal of harmful antibodies, potentially offering innovative solutions in therapeutic applications.
Reference
Product
Platform | REMAb Therapeutics
Remab Therapeutics. Platform of Polymeric Conjugates for Selective Intracorporeal Removal of Specific Harmful Antibodies.
Biohope
Tres Cantos, Spain
A
11-50 Employees
2015
Key takeaway
Biohope Scientific Solutions for human health SL is focused on developing innovative therapies, with its lead product, Immunobiogram®, being a unique in vitro diagnostic platform that optimizes immunosuppressive therapy. This technology is particularly relevant for personalized medicine in conditions like renal transplantation.
Reference
Core business
Home BioHope - Biohope
Biohope`s lead product, Immunobiogram®, is a novel, unique and patented in vitro diagnostic platform which allows the physicians to optimize each individual immunosuppressant. Immunobiogram is the first product from our technological platform. We are adapting our technology to other immune-based conditions.
AMSbiopharma
Spain
A
1-10 Employees
2018
Key takeaway
AMSbiopharma specializes in quality control and analytical services for recombinant proteins and monoclonal antibodies, making it a valuable partner in the biopharmaceutical industry. Their expertise in mass spectrometry and bioinformatics positions them well to support the development and characterization of bispecific antibodies.
Reference
Core business
Header - AMS Biopharma
+34 982 804750 info@amsbiopharma.com Avda. Benigno Rivera, 56. 27003. Lugo. España. Linkedin Twitter About Contact R&D Biopharmaceuticals mAbs Biosimilars Antibody-Drug-Conjugates PEGylated proteins Heavily Glycosylated Proteins Other Recombinant Proteins Peptides Preclinical Research Bioanalysis In vitro ADME Metabolic stability Matrix stability Permeability assays Cytochrome P450 Protein binding Chemical Stability Safety and Toxicology Impurities Impurity Profiling Structural determination […]
BioPharma Synergies
Barcelona, Spain
A
1-10 Employees
2006
Key takeaway
BioPharma Synergies is focused on connecting manufacturers with the European market, enhancing product value and market share. They have an R&D team that supports the development of innovative drug delivery systems, which could be relevant for advancements in bispecific antibody formulations.
Reference
Product
Portfolio | BioPharma Synergies
Syna Therapeutics
Barcelona, Spain
A
1-10 Employees
2018
Key takeaway
The company, a joint venture between Reig Jofre and LeanBio, focuses on developing high-quality biosimilars and innovative molecules to meet the increasing global demand for biological treatments.
Reference
Core business
Syna Therapeutics | Biosimilars and Innovative Molecules
We're a joint venture formed of Reig Jofre and LeanBio to develop biosimilars and innovative molecules to respond to the growing global demand for biological treatments.
Algenex
Pozuelo de Alarcón, Spain
A
1-10 Employees
2005
Key takeaway
Algenex is a biotechnology company that specializes in the production of recombinant proteins, including antigens for diagnostic and therapeutic applications, utilizing its proprietary CrisBio® technology platform. Their innovative Baculovirus vector expression systems enhance the production of various biologics, positioning them to potentially contribute to advancements in areas such as bispecific antibodies.
Reference
Core business
Algenex, european biotech. Transforming protein production.
Algenex is a private biotech company with proprietary and patented technologies to boost the production of recombinant proteins using BVES in insect cells.
Biofabri
O Porriño, Spain
A
51-100 Employees
2008
Key takeaway
Biofabri is dedicated to researching and developing new immunotherapy products, highlighting its commitment to advancing human health through innovative therapeutic approaches.
Reference
Core business
Biofabri - Vaccines and immunotherapy for a healthier planet
Biofabri was founded in 2008 with the strong vision of researching anddeveloping new vaccines and immunotherapy products for Human Health
Technologies which have been searched by others and may be interesting for you:
In the Bispecific Antibody industry in Spain, several key considerations are essential for thorough research. First, regulatory compliance is crucial, as the European Medicines Agency (EMA) oversees the approval of biopharmaceuticals, including bispecific antibodies. Understanding the intricacies of clinical trial requirements and post-market surveillance is important for companies operating in this space. Additionally, the competitive landscape is rapidly evolving, with both established pharmaceutical companies and innovative biotech firms vying for market share. This competition fosters opportunities for collaboration and partnerships, particularly in research and development, which can enhance innovation and streamline the development process. Challenges include high development costs and the technical complexity associated with bispecific antibody design and production. Despite these hurdles, the growing prevalence of cancer and autoimmune diseases presents significant market potential. Environmental concerns are becoming increasingly relevant, especially with the push for sustainable practices in biomanufacturing. Companies must also consider global market relevance, as Spain serves as a strategic gateway to the broader European market, making it vital to stay informed about international trends and regulatory changes. Understanding these factors will provide a comprehensive view for anyone interested in the bispecific antibody sector in Spain.
Some interesting numbers and facts about your company results for Bispecific Antibody
| Country with most fitting companies | Spain |
| Amount of fitting manufacturers | 154 |
| Amount of suitable service providers | 137 |
| Average amount of employees | 1-10 |
| Oldest suiting company | 2005 |
| Youngest suiting company | 2018 |
Some interesting questions that has been asked about the results you have just received for Bispecific Antibody
What are related technologies to Bispecific Antibody?
Based on our calculations related technologies to Bispecific Antibody are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Which industries are mostly working on Bispecific Antibody?
The most represented industries which are working in Bispecific Antibody are Biotechnology, Pharmaceuticals, Healthcare, Medical, Other
How does ensun find these Bispecific Antibody Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.